William Lis
Director at Zai Lab Ltd (ZLAB)
William Lis has filed 27 insider reports with the SEC since January 2021, as director at Zai Lab Ltd (ZLAB), director at Jasper Therapeutics, Inc. (JSPR) and director at Eidos Therapeutics, Inc. (EIDX). In the last 12 months William Lis sold $340K of stock on the open market. In the latest filing, on August 13, 2026, William Lis sold 8,506 shares of Zai Lab Ltd (ZLAB) for $213K at an average of $25.00.
- Filings
- 27
- Companies
- 3
- Bought on market
- None
- Sold on market
- $1.94M
Companies where William Lis is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 22,927 | $1.82M | $21.92 | Aug 13, 2026 | |||
| Directorsince September 2021 | 53,521 | $120K | $10.75 | Mar 6, 2024 | |||
| Director | Jan 29, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 12, 2026-$213KZLABDirector Lis William sold $212,650 worth of American Depositary Shares (8,506 units at $25.00) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 41,931 unitsForm 4Open-market sale10b5-1 plan
- Aug 12, 2026~$213KZLABWilliam Lis plans to sell 8,506 shares (~$213K)Form 144Planned sale10b5-1 plan
- Jun 22, 2026-$127KZLABDirector Lis William sold $127,354 worth of American Depositary Shares (7,040 units at $18.09) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 50,437 unitsForm 4Open-market sale10b5-1 plan
- Jun 17, 2026ZLABDirector Lis William was granted 22,371 units of American Depositary Shares, increasing direct ownership by 64% to 57,477 unitsForm 4Grant or award
- Jun 22, 2026~$127KZLABWilliam Lis plans to sell 7,040 shares (~$127K)Form 144Planned sale10b5-1 plan
- Jun 20, 2025-$493KZLABDirector Lis William was granted 10,831 units of American Depositary Shares and sold $492,745 worth of American Depositary Shares (13,814 units at $35.67), decreasing direct ownership by 8% to 35,106 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jun 20, 2025~$493KZLABWilliam Lis plans to sell 13,814 shares (~$493K)Form 144Planned sale10b5-1 plan
- Feb 28, 2025-$495KZLABDirector Lis William sold $494,700 worth of American Depositary Shares (15,000 units at $32.98), decreasing direct ownership by 28% to 38,089 unitsForm 4Open-market sale10b5-1 plan
- Feb 28, 2025~$495KZLABWilliam Lis plans to sell 15,000 shares (~$495K)Form 144Planned sale10b5-1 plan
- Jul 1, 2024-$180KZLABDirector Lis William sold $180,085 worth of American Depositary Shares (10,397 units at $17.32), decreasing direct ownership by 16% to 53,089 unitsForm 4Open-market sale10b5-1 plan
- Jul 1, 2024~$179KZLABWilliam Lis plans to sell 10,397 shares (~$179K)Form 144Planned sale10b5-1 plan
- Jun 18, 2024ZLABDirector Lis William was granted 21,253 units of American Depositary Shares, increasing direct ownership by 50% to 63,486 unitsForm 4Grant or award
- Mar 6, 2024~$336KJSPRWilliam Lis plans to sell 16,000 shares (~$336K)Form 144Planned sale
- Oct 13, 2023-$6,777JSPRLis William sold $6,777 worth of Voting Common Stock (7,965 units at $0.85), decreasing direct ownership by 13% to 53,521 unitsForm 4Open-market sale10b5-1 plan
- Jun 29, 2023ZLABSEC Form 4 filed by Lis WilliamForm 4Grant or award
- Jun 7, 2023JSPRSEC Form 4 filed by Lis WilliamForm 4Grant or award
- Apr 13, 2023-$12.2KJSPRSEC Form 4 filed by Lis WilliamForm 4Open-market sale
- Mar 3, 2023-$208KZLABSEC Form 4: Lis William sold $208,177 worth of American Depositary Shares (5,434 units at $38.31) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 23,330 unitsForm 4Open-market sale10b5-1 plan
- Oct 12, 2022JSPRSEC Form 4: Lis William was granted 29,500 units of Voting Common Stock, increasing direct ownership by 73% to 69,986 unitsForm 4Grant or award
- Jun 27, 2022-$101KJSPRSEC Form 4: Lis William sold $101,434 worth of Voting Common Stock (49,486 units at $2.05) as part of a pre-agreed trading plan, decreasing direct ownership by 55% to 40,486 unitsForm 4Open-market sale10b5-1 plan
- Mar 21, 2022JSPRSEC Form 4: Lis William was granted 89,972 units of Voting Common StockForm 4Grant or award
- Jan 5, 2021ZLABSEC Form 5: Lis William decreased direct ownership by 19% to 22,927 unitsForm 5Shares withheld for taxes or exercise price10b5-1 plan
- Jan 20, 2022-$103KZLABSEC Form 4: Lis William sold $102,848 worth of Ordinary Shares (1,926 units at $53.40) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 34,114 unitsForm 4Open-market sale10b5-1 plan
- Jan 3, 2022ZLABSEC Form 4: Lis William was granted 7,763 units of Ordinary Shares, increasing direct ownership by 27% to 36,040 unitsForm 4Grant or award
- Sep 24, 2021JSPRWilliam Lis became an insiderForm 3New insider
- Jan 26, 2021EIDXSEC Form 4 filed by William LisForm 4Sale back to the company
- Jan 15, 2021ZLABSEC Form 4: William Lis was granted 3,852 units of Ordinary Shares, increasing ownership by 16% to 28,277 unitsForm 4Grant or award
Compare William Lis with
- William Lis vs Richard Gaynor1 shared
- William Lis vs Yajing Chen1 shared
- William Lis vs Thomas G Wiggans1 shared
- William Lis vs Kurt Von Emster1 shared
- William Lis vs Svetlana Lucas1 shared
- William Lis vs Patrick J Crutcher1 shared
Other insiders at the same companies
- Richard GaynorZLAB
- Yajing ChenZLAB
- Thomas G WiggansJSPR
- Svetlana LucasJSPR
- Kurt Von EmsterJSPR
- Patrick J CrutcherJSPR
- Judith Anne ShizuruJSPR
- Greg KeenanJSPR
- Matthew E RosJSPR
- Wenru SongJSPR
- Du YingZLAB
- Frazor Titus Edmondson IIIZLAB
- John D DiekmanZLAB
- Peter WirthZLAB
- Scott W MorrisonZLAB
- Nisa LeungZLAB
Questions about William Lis
- What is William Lis's role at Zai Lab Ltd?
- William Lis reports to the SEC as director at Zai Lab Ltd (ZLAB), according to the latest filing on August 13, 2026. William Lis has also filed as director at Jasper Therapeutics, Inc. (JSPR) and director at Eidos Therapeutics, Inc. (EIDX).
- How many shares does William Lis own?
- After the latest filing that states it, William Lis directly owned 22,927 shares of Zai Lab Ltd (ZLAB) and 53,521 shares of Jasper Therapeutics, Inc. (JSPR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has William Lis bought or sold stock recently?
- The most recent open-market sale was on August 12, 2026: sold 8,506 shares of Zai Lab Ltd (ZLAB) for $213K at an average of $25.00.
- How do I get alerts when William Lis files?
- Follow William Lis on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by William Lis (SEC CIK 0001574558). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2021 on. View on SEC EDGAR · Get this as JSON